In women KRT15 has been suggested as a marker to differentiate between DCIS and invasive BC, with a correlation of KRT15 expression with histological grade, tumor node stage and tumor node metastasis stage [82]. The gene discussed is KRT15; the disease is ductal breast carcinoma in situ.